Physician profile
Mitch Biermann
NPI 1033671292
$1,416.33
in general payments reported to CMS, 2019-2025
19 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $136 · 2023: $510 · 2024: $619 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,254 · Education: $26.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,253.72 |
| Education | $26.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $374.20 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $219.66 | 2023-2024 | Shingrix, Arexvy, Bexsero |
| Lilly USA, LLC | $148.57 | 2023-2024 | Mounjaro, Jardiance |
| Daiichi Sankyo INC. | $90.79 | 2024-2025 | Injectafer |
| Novartis Pharmaceuticals Corporation | $88.46 | 2023-2024 | |
| Amgen INC. | $68.91 | 2023-2025 | Repatha, Prolia, Evenity |
| Astrazeneca Pharmaceuticals LP | $67.75 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Pfizer INC. | $53.36 | 2023 | |
| Eisai INC. | $47.38 | 2023-2024 | |
| Sanofi-Aventis U.S. LLC | $37.93 | 2024 | |
| Abbvie INC. | $37.38 | 2023-2024 | Ubrelvy |
| Tersera Therapeutics LLC | $33.21 | 2024 | Quzyttir |
| Astellas Pharma US INC | $25.32 | 2024 | Veozah |
| Teleflex LLC | $24.64 | 2024 | Urolift |
| Gilead Sciences, INC. | $24.53 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhythm Pharmaceuticals, INC. | $19.98 | 2023 | Imcivree |
| Currax Pharmaceuticals LLC | $19.01 | 2023 | Contrave |
| Medtronic, INC. | $18.85 | 2024 | Symplicity G3 |
| Irhythm Technologies, INC. | $16.40 | 2024 | Zio Xt Patch, Zio Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitch Biermann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.